Zobrazeno 1 - 10
of 41
pro vyhledávání: '"László, Thurzó"'
Autor:
Peter Molnar, Zoltán Hernádi, Bence Nagy, László Tóth, Gábor Méhes, László Thurzó, Róbert Póka
Publikováno v:
Pathology, research and practice. 213(8)
Background Classical features as histomorphology, grade, FIGO stage, and residual tumour mass have strong prognostic value in advanced epithelial ovarian carcinomas (AEOC). Most AEOCs are associated with early recurrence and poor overall survival (OS
Autor:
Oliver Schnell, Martin J B Taphoorn, Astrid Weyerbrock, Kenneth Aldape, James Perry, Do-Hyun Nam, Roger Stupp, Torsten Pietsch, Wolfgang Wick, Rolf-Dieter Kortmann, Martin J. van den Bent, Andriy Markivskyy, Yong-Kil Hong, Christine Hicking, Louis B. Nabors, Rafal Tarnawski, Benoit Lhermitte, David A. Reardon, Alba A. Brandes, Catherine McBain, Joachim P. Steinbach, Tejpal Gupta, Joerg C. Tonn, László Thurzó, Monika E. Hegi, Thomas Wiegel, Sara Erridge, Martin Picard, Peter Hau, Chae-Yong Kim, Ulrich Herrlinger, Thierry Gorlia, Michael Weller, Chiung-Chyi Shen, Nalini Rao, Krystyna Adamska, Danica Grujicic
Publikováno v:
Stupp, R, Hegi, M E, Gorlia, T, Erridge, S C, Perry, J, Hong, Y K, Aldape, K D, Lhermitte, B, Pietsch, T, Grujicic, D, Steinbach, J P, Wick, W, Tarnawski, R, Nam, D H, Hau, P, Weyerbrock, A, Taphoorn, M J B, Shen, C C, Rao, N, Thurzo, L, Herrlinger, U, Gupta, T, Kortmann, R D, Adamska, K, McBain, C, Brandes, A A, Tonn, J C, Schnell, O, Wiegel, T, Kim, C Y, Nabors, L B, Reardon, D A, van den Bent, M J, Hicking, C, Markivskyy, A, Picard, M & Weller, M 2014, ' Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial ', Lancet Oncology, vol. 15, no. 10, pp. 1100-1108 . https://doi.org/10.1016/S1470-2045(14)70379-1
Lancet Oncology, 15(10), 1100-1108. Lancet Publishing Group
Lancet Oncology, 15(10), 1100-1108. Lancet Publishing Group
Summary Background Cilengitide is a selective αvβ3 and αvβ5 integrin inhibitor. Data from phase 2 trials suggest that it has antitumour activity as a single agent in recurrent glioblastoma and in combination with standard temozolomide chemoradiot
Autor:
Milica Zivaljevic, Aljosa Mandic, Dejan Nincic, Tihomir Dugandzija, László Thurzó, Róbert Berkecz
Publikováno v:
Archive of Oncology. 21:97-100
Background: Ovarian cancer is among the sixth leading cancers in Vojvodina and the fifth leading cause of cancer death among female population in Vojvodina according to Cancer Registry of Vojvodina in 2010. The majority of ovarian cancers cases are d
Autor:
László Thurzó, Emese Fodor, Zoltán Nagy, Adrienn Cserháti, Virág Vincze, Zoltán Varga, Katalin Hideghéty, Anikó Maráz, Erika Szántó
Publikováno v:
Radiotherapy and Oncology. 102:214-218
Purpose To evaluate neuroaxis irradiation for adults in the supine position using head body thermoplastic mask fixation, from the aspects of dose distribution, patient comfort and set-up accuracy. Methods and materials Nine of the 12 adult patients w
Autor:
Krisztina Boda, Adrienn Cserháti, Zoltán Varga, Gyöngyi Kelemen, Zsuzsanna Kahán, László Thurzó
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 80:1109-1116
Purpose To analyze the risk of radiogenic lung damage in breast cancer patients after conformal radiotherapy and different forms of systemic treatment. Methods and Materials In 328 patients receiving sequential taxane-based chemotherapy, concomitant
Autor:
Ervin Tánczos, Sándor Hamar, Zsuzsanna Kahán, Maria Wagnerova, Erika Csörgő, Gabriella Uhercsák, Thomas Brodowicz, Alíz Nikolényi, Melinda Csenki, László Thurzó
Publikováno v:
Pathology & Oncology Research. 18:61-68
There is a need for the selection of those breast cancers where benefit may be attained from the addition of an anthracycline to the adjuvant chemotherapy. The expression of topoisomerase II alpha (TOP2A) protein in 3 cohorts of breast cancers treate
Autor:
Edina Tolnay, László Thurzó
Publikováno v:
Magyar Onkológia. 54:399-408
Publikováno v:
Pathology & Oncology Research. 17:425-428
Breast cancer at a relatively young age with a poor prognosis is currently exhibiting an increasing incidence. In a retrospective cohort analysis of early breast cancer cases after surgery from our institutional patient registry, 141 patients aged
Publikováno v:
Magyar Onkológia. 54:41-45
The aim of this study was to investigate the changes in dietary habits in women with gynecological or breast cancer, and to analyze the role of some demographic factors, type of the malignant tumor, and the role of medical staff ’s advice in dietar
Publikováno v:
Orvosi Hetilap. 150:65-71
Neoadjuvant (preoperative) systemic therapy is a good possibility for the treatment of symptomatic breast cancers of the locoregional stage. Chemotherapy or hormone therapy chosen according to the characteristics of the primary tumor, result in the r